Characteristics of subjects with systemic sclerosis (SSc) (2003–2008).
| Characteristic | Incidence Cohort Subjects n (%) | Prevalence Cohort Subjects n (%) |
|---|---|---|
| SSc (overall) | 1529 (100.0) | 2739 (100.0) |
| Year | ||
| 2003 | 226 (14.8) | 656 (24.0) |
| 2004 | 220 (14.4) | 725 (26.5) |
| 2005 | 232 (15.2) | 757 (27.6) |
| 2006 | 304 (19.9) | 918 (33.5) |
| 2007 | 278 (18.2) | 966 (35.2) |
| 2008 | 269 (17.6) | 1076 (39.3) |
| Age, yrs | ||
| 18–44 | 430 (28.1) | 732 (26.7) |
| 45–64 | 916 (59.9) | 1682 (61.4) |
| 65+ | 183 (12.0) | 325 (11.9) |
| Sex | ||
| Female | 1297 (84.8) | 2357 (86.1) |
| Male | 232 (15.2) | 382 (14.0) |
| Medications (1 Year postindex) | ||
| Methotrexate | 152 (9.9) | 246 (9.0) |
| Cyclosporine | 10 (0.7) | 13 (0.5) |
| Cyclophosphamide | 39 (2.6) | 75 (2.7) |
| Mycophenolate mofetil | 67 (4.4) | 132 (4.8) |
| Corticosteroids | 707 (46.2) | 1213 (44.3) |